Searching for the gatekeeper oncogene of prostate cancer
- 1 June 2003
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 46, 11-20
- https://doi.org/10.1016/s1040-8428(03)00060-x
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor BetaNew England Journal of Medicine, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- β-catenin signaling and cancerBioEssays, 1999
- Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 1997
- Lessons from Hereditary Colorectal CancerCell, 1996
- APC mutations occur early during colorectal tumorigenesisNature, 1992
- A genetic model for colorectal tumorigenesisCell, 1990
- Localization of the gene for familial adenomatous polyposis on chromosome 5Nature, 1987